查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1827229

Cyazofamid市場（按配方、包裝、作物類型、施用方法、最終用戶和分銷管道）—2025-2032 年全球預測

Cyazofamid Market by Formulation, Packaging, Crop Type, Application Mode, End-Users, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，Cyazofamid市場規模將成長至 1.8417 億美元，複合年成長率為 4.30%。

主要市場統計數據
基準年2024年 1.3143億美元
預計2025年 1.3688億美元
預測年份：2032年 1.8417億美元
複合年成長率（%） 4.30%

全面了解Cyazofamid，重點介紹其對作物保護決策者的監管背景和農藝效用的商業性意義

Cyazofamid因其針對性強，可有效殺死部分威脅高價值蔬菜、水果和種子作物的真菌病原體，已成為現代殺菌劑產品組合中的重要工具。其農藝特性，以選擇性活性和與綜合蟲害管理方法的兼容性為特徵，使其在保持產量品質的同時，滿足監管和永續性預期，為種植者提供了策略性優勢。因此，從配方師到經銷商，行業相關人員都在密切關注登記趨勢、應用實踐以及不同地區種植者不斷變化的需求。

本概述從多方相關人員的觀點對Cyazofamid進行了研究。從農藝角度來看，抗性管理、施用機器以及與混合劑型合作夥伴的兼容性將決定其在農場的效用。本文件旨在幫助決策者了解產品管理、製劑投資和分銷規劃的短期戰術性考量和長期策略影響。本文件關注實際使用案例和系統性促進因素，將實驗室有效性與田間應用和商業性可行性聯繫起來，而無需假設不同地區和作物系統的條件一致。

永續性數位農業和彈性供應鏈策略如何重塑Cyazofamid商業化和管理的全球方法

多種趨勢正在改變Cyazofamid在作物保護產品組合中的地位，迫使企業重新思考其製劑策略、分銷模式和管理方案。永續性的要求和消費者的期望提高了對具有選擇性功效和良好環境特徵的活性成分的要求，導致投資重點轉向低風險化學和精準施用方法。同時，數位農學工具和遙感探測正在使干涉措施更具針對性，並將其與強大的病害預測系統相結合，可以更精確地定時施用殺菌劑，並降低每公頃土地的總施用量。

同時，全球供應鏈面臨的壓力加速了製造和採購多元化的需求，促使製劑製造商與區域委託製造商合作，以縮短前置作業時間並增強韌性。監管機構日益協調環境歸宿和人類健康終點的資料要求，促使註冊人投資於擴展的檔案和註冊後監測。最後，抗藥性管理如今已成為一項重要的商業考量。將標籤說明與種植者教育和輪作策略相結合的管理計劃，對於保持產品壽命、保護農場收益以及與綜合疾病管理理念保持一致至關重要。

評估2025年美國關稅對Cyazofamid唑採購彈性、供應鏈決策和分銷經濟的連鎖反應

美國2025年的關稅環境產生了一系列結構性影響，波及整個作物保護化學品價值鏈，影響了採購、依賴進口的製劑製程和定價動態。某些化學中間體和成品作物保護產品的關稅上調，增加了依賴跨境供應的企業的成本基礎，這些成本壓力促使它們重新評估採購、重新談判合約並調整庫存策略。重要的是，這種環境有利於垂直整合的製造商和具有本地生產能力的區域供應商，而依賴即時進口的企業則必須透過緩衝庫存和替代採購安排來適應。

除了直接的成本影響外，關稅情勢也影響了優先選擇哪些劑型和包裝形式進行國內分銷的策略決策。企業重新考慮了大宗進口與本地配方和填充的可行性，一些企業選擇將增值業務遷至更靠近需求中心的地方，以減輕關稅的影響。在分銷層面，經銷商和合作社面臨利潤壓縮，他們必須透過定價策略、產品捆綁銷售和增強服務差異化來應對。此外，政策背景加強了對供應鏈透明度的審查，促使企業採取更積極的供應商資格審查、製造外包審核和緊急時應對計畫，以確保依賴含Cyazofamid唑產品的生產商的關鍵投入持續供應。

對產品配方、包裝、應用形式和通路的細分主導，決定Cyazofamid的採用和管理實踐

要了解Cyazofamid的需求促進因素，需要詳細了解劑型類別、包裝選擇、目標作物、施用形式、最終用戶類型和通路。從乳油到懸浮劑再到可濕性顆粒劑，劑型的選擇決定了罐混適用性、施用便利性和使用者安全性，從而影響產品的使用地點和方式。袋裝、散裝和桶裝等包裝形式會影響物流、農場級處理以及對不同規模作業的適用性，每種形式都會影響儲存、運輸成本和補充流程。

穀物和穀類、水果和蔬菜以及油籽和豆類各自具有不同的病害壓力、收穫時間和抗性閾值，這些都決定了施用時間和標籤建議。航空噴霧有利於大面積作物，而滴灌和種子處理則是針對特定生產系統的更有針對性的施用機制。葉面噴布和土壤處理仍然是許多種植者的主要途徑，這取決於疾病流行病學和作物物候學。最終用戶多種多樣，包括優先考慮批量採購和諮詢服務的農業合作社、需要可預測供應和技術支援的商業農民、重視一致性和產量的合約種植者和相關企業，以及優先考慮研究應用和培訓材料的教育機構。分銷通路分為以當地經銷商和農藝師為中心的線下關係以及提供便利和數據主導訂購的線上平台。每個管道都會影響向最終用戶提供技術支援、監管文件和售後管理的方式。

每個管道都會影響技術支援、監管文件和上市後管理的交付方式。細分視角凸顯了差異化市場策略的必要性。產品團隊必須將配方開發與應用偏好結合，選擇能夠反映用戶規模和物流實際情況的包裝形式，並設計在保持技術支援的同時適應數位訂購行為的銷售協議。此類基於細分的調整有助於Cyazofamid在作物系統和分銷網路中有效部署，從而提高其被採用的可能性，同時又能遵循管理目標。

美洲、歐洲、中東和非洲以及亞太地區的區域差異將決定Cyazofamid的監管優先供應策略和採用途徑

區域動態從根本上影響Cyazofamid的監管時間表、疾病流行情況和商業性途徑，識別這些差異對於確定市場參與度和資源分配的優先順序至關重要。在美洲，從大規模大田作物到集約化蔬菜生產的多樣化生產系統需要靈活的供應鏈和強大的技術支援。法律規範強調殘留監測和標籤合規性，進而影響產品註冊和推廣工作。在歐洲、中東和非洲，法規環境通常涉及跨司法管轄區的複雜協調，同時更加關注環境終點，因此需要採取嚴謹的方法來開發包裝說明書，並提供本地測試證據來附加檔聲明。

在亞太地區，園藝生產的快速集約化以及溫暖潮濕環境下病害的高壓力使得有效的防治方案具有戰略意義。本地製造能力、接近性原料供應商以及針對小農戶和商業種植者的客製化教育計畫影響著採用的速度。這些地區差異凸顯了差異化註冊策略、本地化管理計畫以及反映物流現實的供應鏈配置的必要性。此外，跨區域知識轉移和有針對性的田間試驗可以增強種植者的信心，但要有效，這些措施必須適應當地的農業實踐和氣候限制。

領先的註冊人和供應鏈合作夥伴如何結合研發監管專業知識和商業性夥伴關係，以保護Cyazofamid的功效並延長產品的效用

積極參與Cyazofamid的公司正優先考慮產品管理、製劑創新和商業性夥伴關係，以保護資產價值並擴大農場效用。研發投入主要集中在製劑平台上，旨在改善操作特性、增強殘留活性並增強與精準施用系統的兼容性。這些技術進步與不斷擴大的田間試驗計畫同步進行，旨在驗證其在不同區域病害壓力和種植系統中的性能，為擴大產品標籤範圍和增強種植者信心提供必要的實證基礎。

商業性，註冊商、契約製造和區域經銷商之間的策略聯盟能夠快速回應本地需求，同時降低供應鏈風險。智慧財產權管理和監管專業知識仍然是競爭優勢，因為能夠有效處理資料打包、公差和管理義務的公司更有能力確保和維護註冊。最後，企業正在投資數位支援工具和農藝培訓，以提高實施的準確性並減少可能加速抗藥性的濫用，從而延長Cyazofamid作為綜合蟲害管理計劃工具的使用壽命。

產業領導者可以採取切實可行的策略行動，以加強管理、最佳化供應鏈並協調商業性執行，以便在不同的作物系統中採用Cyazofamid

產業領導者應積極主動整合監管規劃、供應鏈韌性和生產者參與，以最大限度地提升Cyazofamid的策略價值。優先投資先進製劑研究，以更好地適應該藥物的小批量精準應用平台，並提升其用戶安全性。同時，多元化製造外包和採購安排，以減少受關稅影響的供應鏈風險，並實現在需求中心附近快速擴張生產。加強供應商資格認證、審核實務和庫存緩衝策略，以降低政策突然轉變和物流中斷帶來的脆弱性。

我們將結合標籤指南和提供施用時機、抗藥性管理提醒以及區域最佳實踐建議的數位工具，強化我們的管理計畫。我們將根據市場區隔的實際情況調整包裝形式和分銷模式，並投資田間示範項目，以贏得商業化種植者和合作社的偏好。最後，為了支持負責任的使用和市場准入，我們將透過社區為基礎的檢測和殘留研究建立依證，同時採取「法規優先」的市場准入方式，預測文件要求，並積極與主管部門合作，盡可能加快核准。

透明的混合方法研究框架，將二級監管分析與主要相關人員訪談和三角測量相結合，以確保可靠的Cyazofamid情報

研究途徑結合了結構化的二次分析、有針對性的一手訪談和嚴格的三角測量，從而對Cyazofamid的市場格局提供了深入的了解。二次分析的輸入包括官方監管備案文件、同行評審的農藝學和植物病理學文獻，以及記錄標籤聲明和針對主要真菌病原體的田間藥效的行業出版物。一手研究包括對農學家、製劑科學家、監管專家、經銷商和商業種植者的訪談，以了解實際使用情況、購買行為以及公共記錄中未必經常記錄的營運限制。

資料合成透過多層驗證流程完成，該流程將訪談見解與監管文件和實地檢驗報告進行交叉核對，找出趨同點和分歧點，並透過與領域專家的後續跟進協調相互矛盾的意見。敏感性檢定旨在評估定性結論的穩健性，並強調調查方法的局限性，因為區域資料缺口或快速變化的政策情勢會導致不確定性。這種透明的調查方法為分析提供了支撐，確保結論能夠反映對現有證據的均衡解讀，並突出了需要額外收集原始數據才能增值的領域。

關鍵策略槓桿的整合將決定Cyazofamid在不斷變化的監管和供應環境中的長期商業性和農藝可行性

Cyazofamid因其精準的功效特性以及與綜合病害管理方法的兼容性，在現代殺菌劑套件中佔據戰略地位。Cyazofamid的商業性前景取決於在製劑開發、監管策略、供應鏈韌性和種植者管理專案方面的協調投資。不斷變化的監管預期、關稅主導的供應鏈重組以及精準農業日益重要的作用等多重壓力，使得我們必須採取一種將技術創新與現實的商業性實施相結合的整體方法。

決策者不應將Cyazofamid視為一種獨立的產品，而應將其視為更廣泛的作物保護策略的組成部分，該策略必須透過合作夥伴關係、本地證據收集和自適應分銷系統進行積極管理。關注這些方面將使相關人員能夠更好地保護產品的有效性，最佳化其在不同作物體系中的應用，並更靈活地應對外部衝擊和政策變化。

目錄

第1章 引言

第2章分析方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 歐洲有機馬鈴薯生產中越來越多採用Cyazofamid生物殺菌劑
  • 將Cyazofamid納入綜合害蟲管理計劃，預防晚疫病抗性
  • 透過農化公司之間的策略聯盟開發下一代微膠囊化Cyazofamid製劑
  • 監管審查時間表對Cyazofamid在亞太地區主要地區的供應和市場進入的影響
  • 高價值蔬菜作物病害防治需求不斷成長導致價格波動

第6章：美國關稅的累積影響（2025年）

第7章：人工智慧（AI）的累積影響（2025年）

第 8 章Cyazofamid市場（按劑型）

  • 乳劑
  • 懸浮濃縮液
  • 水合顆粒

第9章Cyazofamid市場：依包裝分類

  • 包包
  • 大部分
  • 鼓

第10章Cyazofamid市場（依作物類型）

  • 糧食
  • 水果和蔬菜
  • 油籽和豆類

第 11 章Cyazofamid市場（按應用）

  • 空中噴灑
  • 滴灌
  • 葉面噴布
  • 種子處理
  • 土壤處理

第 12 章Cyazofamid市場：按最終用戶分類

  • 農業合作社
  • 商業農場
  • 合約種植者和相關企業
  • 教育機構

第13章Cyazofamid市場通路

  • 離線
  • 線上

第14章Cyazofamid市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章Cyazofamid市場：依類別

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章Cyazofamid市場（按國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章競爭格局

  • 市佔率分析（2024年）
  • FPNV定位矩陣（2024年）
  • 競爭分析
    • BASF SE
    • Bayer AG
    • Corteva, Inc.
    • Syngenta AG
    • FMC Corporation
    • UPL Ltd.
    • Sumitomo Chemical Co., Ltd.
    • Nippon Soda Co. Ltd.
    • Koppert Biological Systems
    • Bioworks, Inc.
    • STK Bio-ag Technologies
    • Seipasa SA
    • Ishihara Sangyo Kaisha, Ltd.
    • ADAMA Ltd.
    • STAR BIO SCIENCE
    • National Analytical Corporation
Product Code: MRR-81515600A93D

The Cyazofamid Market is projected to grow by USD 184.17 million at a CAGR of 4.30% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 131.43 million
Estimated Year [2025] USD 136.88 million
Forecast Year [2032] USD 184.17 million
CAGR (%) 4.30%

A comprehensive orientation to cyazofamid that clarifies agronomic utility regulatory context and commercial relevance for crop protection decision-makers

Cyazofamid has emerged as a critical tool in modern fungicide portfolios because of its targeted efficacy against a subset of oomycete pathogens that threaten high-value vegetable, fruit, and seed crops. Its agronomic profile, characterized by selective activity and compatibility with integrated pest management approaches, places it in a strategic position for growers seeking to preserve yield quality while managing regulatory and sustainability expectations. As a consequence, industry stakeholders from formulators to distributors are paying close attention to registration trends, application practices, and the evolving demands of growers across diverse geographies.

This introduction frames cyazofamid from multiple stakeholder perspectives. From a regulatory vantage point, the compound's approval pathways and label expansions are pivotal for commercial adoption; from an agronomic perspective, resistance management, timing of applications, and compatibility with tank-mix partners determine on-farm utility. The synthesis that follows is structured to help decision-makers understand both near-term tactical considerations and the longer-term strategic implications for product stewardship, formulation investment, and channel planning. By focusing on practical use cases and systemic drivers, the narrative connects laboratory efficacy to field adoption and commercial viability without presuming uniform conditions across regions or crop systems.

How sustainability mandates digital agronomy and resilient supply chain strategies are reshaping the global approach to cyazofamid commercialization and stewardship

Several converging trends are transforming how cyazofamid is positioned within crop protection portfolios, compelling companies to rethink formulation strategy, distribution models, and stewardship programs. Sustainability mandates and consumer expectations are raising the bar for active ingredients that demonstrate selective efficacy with a favorable environmental profile, which in turn shapes investment priorities around reduced-risk chemistry and precision application methods. Concurrently, digital agronomy tools and remote sensing are enabling more targeted interventions, allowing fungicides to be deployed with greater timing precision and lower overall volume per hectare when integrated with robust disease forecasting systems.

At the same time, pressure on global supply chains has accelerated the need for diversification of manufacturing and sourcing, encouraging partnerships between formulators and regional toll manufacturers to shorten lead times and enhance resilience. Regulatory authorities are increasingly harmonizing data requirements around environmental fate and human health endpoints, prompting registrants to invest in expanded dossiers and post-registration monitoring. Finally, resistance management is now a core commercial consideration; stewardship programs that combine label directions with grower education and rotation strategies are becoming essential to preserve product lifetime, protect farmer returns, and maintain alignment with integrated disease management philosophies.

Evaluating the ripple effects of the United States tariffs implemented in 2025 on procurement resilience supply chain decisions and distribution economics for cyazofamid

The tariff environment introduced in the United States in 2025 created a set of structural effects that ripple through procurement, import-dependent formulation processes, and pricing dynamics across the crop protection value chain. Increased duties on certain chemical intermediates and finished agrochemical products elevated the cost base for companies reliant on cross-border supply, and these cost pressures prompted sourcing reviews, contractual renegotiations, and adjustments to inventory strategies. Importantly, this environment favored vertically integrated manufacturers and regional suppliers with local production capacity, while companies dependent on just-in-time imports had to adapt through buffer stocks or alternative sourcing arrangements.

Beyond direct cost implications, the tariff landscape influenced strategic decisions about which formulations and packaging formats to prioritize for domestic distribution. Companies reassessed the viability of bulk imports versus localized formulation and filling, with some electing to move value-added operations closer to demand centers to mitigate tariff exposure. At the distribution level, dealers and cooperatives faced margin compression that had to be managed through pricing strategies, product bundling, or increased service differentiation. In addition, the policy backdrop increased scrutiny of supply chain transparency, spurring more active supplier qualification, contract manufacturing audits, and contingency planning to ensure continuity of critical inputs for growers reliant on cyazofamid-containing products.

Segment-driven insights into product formulation packaging application modes and distribution pathways that determine adoption and stewardship practices for cyazofamid

Understanding demand drivers for cyazofamid requires a granular view across formulation categories, packaging options, crop targets, application modes, end-user types, and distribution pathways. Formulation choices-ranging from emulsifiable concentrate to suspension concentrate and wettable granules-determine tank-mix compatibility, application convenience, and user safety considerations, and therefore influence where and how the product is adopted. Packaging formats such as bag, bulk, and drum affect logistics, farm-level handling, and suitability for different scales of operation, with each format carrying implications for storage, transport costs, and refill workflows.

Crop-specific dynamics play a decisive role in product positioning; cereals and grains, fruits and vegetables, and oilseeds and pulses each present distinct disease pressures, harvest windows, and tolerance thresholds that shape application timing and label recommendations. Application modes are equally consequential: aerial application offers coverage advantages for broad-acre crops, while drip irrigation and seed treatment present more targeted delivery mechanisms for certain production systems; foliar spray and soil treatment remain core routes for many growers depending on disease epidemiology and crop phenology. End-users are heterogeneous, spanning agricultural cooperatives that emphasize bulk procurement and advisory services, commercial farmers who require predictable supply and tech support, contract growers and agribusinesses focused on consistency and throughput, and educational institutes that prioritize research access and training materials. Distribution channels bifurcate into offline relationships anchored by local dealers and agronomists and online platforms that offer convenience and data-driven ordering; each channel affects how technical support, regulatory documentation, and post-sale stewardship are delivered to the end-user.

Taken together, the segmentation lens highlights the need for differentiated go-to-market approaches. Product teams must align formulation development with application method preferences, select packaging formats that reflect user scale and logistical realities, and design distribution agreements that preserve technical support while adapting to digital ordering behaviors. This segmentation-informed alignment supports more efficient deployment of cyazofamid across crop systems and distribution networks, improving adoption potential while safeguarding stewardship objectives.

Regional differentiation across the Americas Europe Middle East & Africa and Asia-Pacific that dictates regulatory priorities supply strategies and adoption pathways for cyazofamid

Regional dynamics exert foundational influence on regulatory timelines, disease prevalence, and commercial pathways for cyazofamid, and discerning these differences is essential for prioritizing market engagement and resource allocation. In the Americas, diverse production systems from large-scale field crops to intensive vegetable production demand flexible supply arrangements and robust technical support; regulatory frameworks emphasize residue monitoring and label compliance, shaping how product registrations and extension activities are sequenced. Across Europe, Middle East & Africa, the regulatory environment often involves complex harmonization across jurisdictions alongside heightened focus on environmental endpoints, which necessitates a disciplined approach to dossier development and local trial evidence to support label claims.

In the Asia-Pacific region, rapid intensification of horticultural production and high disease pressure in warm, humid environments elevate the strategic importance of effective oomycete control solutions. Local manufacturing capacity, proximity to raw material suppliers, and tailored education programs for smallholder and commercial growers influence the pace of adoption. These regional variant conditions underline the need for differentiated registration strategies, localized stewardship programs, and supply chain configurations that reflect logistical realities. Moreover, cross-regional knowledge transfer and targeted field demonstration trials can accelerate confidence among growers, yet must be adapted to local agronomic practices and climatic constraints to be effective.

How leading registrants and supply chain partners are aligning R&D regulatory expertise and commercial partnerships to safeguard efficacy and extend product utility for cyazofamid

Companies active around cyazofamid are prioritizing a combination of product stewardship, formulation innovation, and commercial partnerships to protect asset value and extend on-farm utility. Research investment is concentrating on formulation platforms that improve handling characteristics, enhance residual activity, and increase compatibility with precision application systems. These technical advances are being pursued alongside expanded field trial programs designed to demonstrate performance under local disease pressures and cropping sequences, providing the empirical basis necessary for label expansions and grower confidence.

Commercially, strategic alliances between registrants, contract manufacturers, and regional distributors are enabling faster response to local demand while mitigating supply chain risk. Intellectual property management and regulatory expertise remain competitive differentiators, as companies that can efficiently navigate data packages, tolerances, and stewardship obligations are better positioned to secure and defend registrations. Finally, companies are investing in digital support tools and agronomic training to improve adoption fidelity and to reduce misuse that could accelerate resistance, thereby protecting the longevity of cyazofamid as a tool within integrated pest management programs.

Practical strategic actions industry leaders can implement to strengthen stewardship optimize supply chains and align commercial execution for cyazofamid adoption across diverse crop systems

Industry leaders should take a proactive stance that integrates regulatory planning, supply chain resilience, and grower engagement to maximize the strategic value of cyazofamid. Prioritize investments in advanced formulation research that enhances compatibility with low-volume precision application platforms and improves user safety profiles; these technical improvements can create differentiated value propositions across crops and regions. Concurrently, diversify contract manufacturing and sourcing arrangements to reduce exposure to tariff-affected supply chains and enable rapid scaling of production near demand centers. Strengthening supplier qualification, auditing practices, and inventory buffer strategies will reduce vulnerability to sudden policy shifts or logistical disruptions.

Elevate stewardship programs by coupling label guidance with digital tools that provide application timing, resistance management reminders, and localized best-practice recommendations; this will preserve efficacy and protect long-term product value. Tailor commercial strategies to segmentation realities by aligning packaging formats and distribution models with user scale and procurement preferences, and invest in field demonstration programs to build confidence among commercial farmers and cooperatives. Finally, adopt a regulatory-first approach for market entry that anticipates dossier requirements and engages proactively with authorities to expedite approvals where feasible, while building an evidence base through localized trials and residue studies to support responsible use and market access.

A transparent mixed-methods research framework combining secondary regulatory analysis primary stakeholder interviews and triangulation to ensure robust cyazofamid intelligence

The research approach combines structured secondary analysis, targeted primary interviews, and rigorous triangulation to produce a defensible understanding of the cyazofamid landscape. Secondary inputs include public regulatory filings, peer-reviewed agronomy and plant pathology literature, and trade publications that document label language and documented field efficacy against key oomycete pathogens. Primary research involved consultative interviews with agronomists, formulation scientists, regulatory specialists, distributors, and commercial growers to capture real-world application practices, purchasing behaviors, and operational constraints that do not always appear in public records.

Data synthesis was accomplished through a layered validation process: cross-referencing interview insights against regulatory documentation and field trial reports, identifying points of convergence and divergence, and reconciling conflicting inputs through follow-up engagement with subject-matter experts. Sensitivity checks were used to assess the robustness of qualitative conclusions, and methodological limitations were made explicit where regional data gaps or rapidly evolving policy contexts introduced uncertainty. This transparent methodology underpins the analysis and ensures that conclusions reflect a balanced interpretation of available evidence while highlighting areas where additional primary data collection could add value.

A conclusive synthesis of the strategic levers that will determine the long-term commercial and agronomic viability of cyazofamid across changing regulatory and supply environments

Cyazofamid occupies a strategic niche within modern fungicide toolkits due to its targeted efficacy profile and compatibility with integrated disease management practices. Its commercial prospects hinge on coordinated investments across formulation development, regulatory strategy, supply chain resilience, and grower-facing stewardship programs. The combined pressures of evolving regulatory expectations, tariff-driven supply chain recalibration, and the increasing role of precision agronomy require a holistic approach that aligns technical innovation with pragmatic commercial execution.

Decision-makers should view cyazofamid not as a standalone commodity but as a component of a broader crop protection strategy that must be actively managed through collaborative partnerships, localized evidence generation, and adaptive distribution systems. By focusing on these dimensions, stakeholders can better protect product efficacy, optimize adoption across heterogeneous cropping systems, and respond more nimbly to external shocks and policy shifts.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of cyazofamid-based biofungicides in European organic potato cultivation
  • 5.2. Integration of cyazofamid into integrated pest management programs to prevent Phytophthora resistance
  • 5.3. Strategic collaborations between agrochemical firms to develop next generation microencapsulated cyazofamid formulations
  • 5.4. Impact of regulatory review timelines on cyazofamid availability and market entry in key Asia Pacific regions
  • 5.5. Rising demand for late blight control in high value vegetable crops driving cyazofamid price volatility

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cyazofamid Market, by Formulation

  • 8.1. Emulsifiable Concentrate
  • 8.2. Suspension Concentrate
  • 8.3. Wettable Granules

9. Cyazofamid Market, by Packaging

  • 9.1. Bag
  • 9.2. Bulk
  • 9.3. Drum

10. Cyazofamid Market, by Crop Type

  • 10.1. Cereals & Grains
  • 10.2. Fruits & Vegetables
  • 10.3. Oilseeds & Pulses

11. Cyazofamid Market, by Application Mode

  • 11.1. Aerial Application
  • 11.2. Drip Irrigation
  • 11.3. Foliar Spray
  • 11.4. Seed Treatment
  • 11.5. Soil Treatment

12. Cyazofamid Market, by End-Users

  • 12.1. Agricultural Cooperatives
  • 12.2. Commercial Farmers
  • 12.3. Contract Growers & Agribusinesses
  • 12.4. Educational Institutes

13. Cyazofamid Market, by Distribution Channel

  • 13.1. Offline
  • 13.2. Online

14. Cyazofamid Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Cyazofamid Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Cyazofamid Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. BASF SE
    • 17.3.2. Bayer AG
    • 17.3.3. Corteva, Inc.
    • 17.3.4. Syngenta AG
    • 17.3.5. FMC Corporation
    • 17.3.6. UPL Ltd.
    • 17.3.7. Sumitomo Chemical Co., Ltd.
    • 17.3.8. Nippon Soda Co. Ltd.
    • 17.3.9. Koppert Biological Systems
    • 17.3.10. Bioworks, Inc.
    • 17.3.11. STK Bio-ag Technologies
    • 17.3.12. Seipasa S.A.
    • 17.3.13. Ishihara Sangyo Kaisha, Ltd.
    • 17.3.14. ADAMA Ltd.
    • 17.3.15. STAR BIO SCIENCE
    • 17.3.16. National Analytical Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CYAZOFAMID MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CYAZOFAMID MARKET SIZE, BY FORMULATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CYAZOFAMID MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CYAZOFAMID MARKET SIZE, BY PACKAGING, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CYAZOFAMID MARKET SIZE, BY PACKAGING, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CYAZOFAMID MARKET SIZE, BY END-USERS, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CYAZOFAMID MARKET SIZE, BY END-USERS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CYAZOFAMID MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS CYAZOFAMID MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA CYAZOFAMID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA CYAZOFAMID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CYAZOFAMID MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE CYAZOFAMID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST CYAZOFAMID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA CYAZOFAMID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC CYAZOFAMID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL CYAZOFAMID MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN CYAZOFAMID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC CYAZOFAMID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION CYAZOFAMID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS CYAZOFAMID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 CYAZOFAMID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO CYAZOFAMID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL CYAZOFAMID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. CYAZOFAMID MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. CYAZOFAMID MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CYAZOFAMID MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CYAZOFAMID MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CYAZOFAMID MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CYAZOFAMID MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CYAZOFAMID MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CYAZOFAMID MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CYAZOFAMID MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CYAZOFAMID MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CYAZOFAMID MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CYAZOFAMID MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CYAZOFAMID MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CYAZOFAMID MARKET SIZE, BY SUSPENSION CONCENTRATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CYAZOFAMID MARKET SIZE, BY SUSPENSION CONCENTRATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CYAZOFAMID MARKET SIZE, BY SUSPENSION CONCENTRATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CYAZOFAMID MARKET SIZE, BY SUSPENSION CONCENTRATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CYAZOFAMID MARKET SIZE, BY SUSPENSION CONCENTRATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CYAZOFAMID MARKET SIZE, BY SUSPENSION CONCENTRATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CYAZOFAMID MARKET SIZE, BY WETTABLE GRANULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CYAZOFAMID MARKET SIZE, BY WETTABLE GRANULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CYAZOFAMID MARKET SIZE, BY WETTABLE GRANULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CYAZOFAMID MARKET SIZE, BY WETTABLE GRANULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CYAZOFAMID MARKET SIZE, BY WETTABLE GRANULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CYAZOFAMID MARKET SIZE, BY WETTABLE GRANULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CYAZOFAMID MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CYAZOFAMID MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CYAZOFAMID MARKET SIZE, BY BAG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CYAZOFAMID MARKET SIZE, BY BAG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CYAZOFAMID MARKET SIZE, BY BAG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CYAZOFAMID MARKET SIZE, BY BAG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CYAZOFAMID MARKET SIZE, BY BAG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CYAZOFAMID MARKET SIZE, BY BAG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CYAZOFAMID MARKET SIZE, BY BULK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CYAZOFAMID MARKET SIZE, BY BULK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CYAZOFAMID MARKET SIZE, BY BULK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CYAZOFAMID MARKET SIZE, BY BULK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CYAZOFAMID MARKET SIZE, BY BULK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CYAZOFAMID MARKET SIZE, BY BULK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CYAZOFAMID MARKET SIZE, BY DRUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CYAZOFAMID MARKET SIZE, BY DRUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CYAZOFAMID MARKET SIZE, BY DRUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CYAZOFAMID MARKET SIZE, BY DRUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CYAZOFAMID MARKET SIZE, BY DRUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CYAZOFAMID MARKET SIZE, BY DRUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CYAZOFAMID MARKET SIZE, BY CEREALS & GRAINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CYAZOFAMID MARKET SIZE, BY CEREALS & GRAINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CYAZOFAMID MARKET SIZE, BY CEREALS & GRAINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CYAZOFAMID MARKET SIZE, BY CEREALS & GRAINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CYAZOFAMID MARKET SIZE, BY CEREALS & GRAINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CYAZOFAMID MARKET SIZE, BY CEREALS & GRAINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CYAZOFAMID MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CYAZOFAMID MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CYAZOFAMID MARKET SIZE, BY FRUITS & VEGETABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CYAZOFAMID MARKET SIZE, BY FRUITS & VEGETABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CYAZOFAMID MARKET SIZE, BY FRUITS & VEGETABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CYAZOFAMID MARKET SIZE, BY FRUITS & VEGETABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CYAZOFAMID MARKET SIZE, BY OILSEEDS & PULSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CYAZOFAMID MARKET SIZE, BY OILSEEDS & PULSES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CYAZOFAMID MARKET SIZE, BY OILSEEDS & PULSES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CYAZOFAMID MARKET SIZE, BY OILSEEDS & PULSES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CYAZOFAMID MARKET SIZE, BY OILSEEDS & PULSES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CYAZOFAMID MARKET SIZE, BY OILSEEDS & PULSES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CYAZOFAMID MARKET SIZE, BY AERIAL APPLICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CYAZOFAMID MARKET SIZE, BY AERIAL APPLICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CYAZOFAMID MARKET SIZE, BY AERIAL APPLICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CYAZOFAMID MARKET SIZE, BY AERIAL APPLICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CYAZOFAMID MARKET SIZE, BY AERIAL APPLICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CYAZOFAMID MARKET SIZE, BY AERIAL APPLICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CYAZOFAMID MARKET SIZE, BY DRIP IRRIGATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CYAZOFAMID MARKET SIZE, BY DRIP IRRIGATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CYAZOFAMID MARKET SIZE, BY DRIP IRRIGATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CYAZOFAMID MARKET SIZE, BY DRIP IRRIGATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CYAZOFAMID MARKET SIZE, BY DRIP IRRIGATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CYAZOFAMID MARKET SIZE, BY DRIP IRRIGATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CYAZOFAMID MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CYAZOFAMID MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CYAZOFAMID MARKET SIZE, BY FOLIAR SPRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CYAZOFAMID MARKET SIZE, BY FOLIAR SPRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CYAZOFAMID MARKET SIZE, BY FOLIAR SPRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CYAZOFAMID MARKET SIZE, BY FOLIAR SPRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CYAZOFAMID MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CYAZOFAMID MARKET SIZE, BY SEED TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CYAZOFAMID MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CYAZOFAMID MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CYAZOFAMID MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CYAZOFAMID MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CYAZOFAMID MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CYAZOFAMID MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CYAZOFAMID MARKET SIZE, BY SOIL TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CYAZOFAMID MARKET SIZE, BY SOIL TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CYAZOFAMID MARKET SIZE, BY SOIL TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CYAZOFAMID MARKET SIZE, BY SOIL TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CYAZOFAMID MARKET SIZE, BY END-USERS, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CYAZOFAMID MARKET SIZE, BY END-USERS, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CYAZOFAMID MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CYAZOFAMID MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CYAZOFAMID MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CYAZOFAMID MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CYAZOFAMID MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CYAZOFAMID MARKET SIZE, BY AGRICULTURAL COOPERATIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CYAZOFAMID MARKET SIZE, BY COMMERCIAL FARMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CYAZOFAMID MARKET SIZE, BY COMMERCIAL FARMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CYAZOFAMID MARKET SIZE, BY COMMERCIAL FARMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CYAZOFAMID MARKET SIZE, BY COMMERCIAL FARMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CYAZOFAMID MARKET SIZE, BY COMMERCIAL FARMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CYAZOFAMID MARKET SIZE, BY COMMERCIAL FARMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CYAZOFAMID MARKET SIZE, BY CONTRACT GROWERS & AGRIBUSINESSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CYAZOFAMID MARKET SIZE, BY CONTRACT GROWERS & AGRIBUSINESSES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CYAZOFAMID MARKET SIZE, BY CONTRACT GROWERS & AGRIBUSINESSES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CYAZOFAMID MARKET SIZE, BY CONTRACT GROWERS & AGRIBUSINESSES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CYAZOFAMID MARKET SIZE, BY CONTRACT GROWERS & AGRIBUSINESSES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CYAZOFAMID MARKET SIZE, BY CONTRACT GROWERS & AGRIBUSINESSES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CYAZOFAMID MARKET SIZE, BY EDUCATIONAL INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CYAZOFAMID MARKET SIZE, BY EDUCATIONAL INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CYAZOFAMID MARKET SIZE, BY EDUCATIONAL INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CYAZOFAMID MARKET SIZE, BY EDUCATIONAL INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CYAZOFAMID MARKET SIZE, BY EDUCATIONAL INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CYAZOFAMID MARKET SIZE, BY EDUCATIONAL INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CYAZOFAMID MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CYAZOFAMID MARKET SIZE, BY OFFLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CYAZOFAMID MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CYAZOFAMID MARKET SIZE, BY OFFLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CYAZOFAMID MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CYAZOFAMID MARKET SIZE, BY OFFLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CYAZOFAMID MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CYAZOFAMID MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CYAZOFAMID MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CYAZOFAMID MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CYAZOFAMID MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CYAZOFAMID MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CYAZOFAMID MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CYAZOFAMID MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS CYAZOFAMID MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS CYAZOFAMID MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS CYAZOFAMID MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS CYAZOFAMID MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS CYAZOFAMID MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS CYAZOFAMID MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS CYAZOFAMID MARKET SIZE, BY END-USERS, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS CYAZOFAMID MARKET SIZE, BY END-USERS, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA CYAZOFAMID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA CYAZOFAMID MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA CYAZOFAMID MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA CYAZOFAMID MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA CYAZOFAMID MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA CYAZOFAMID MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA CYAZOFAMID MARKET SIZE, BY END-USERS, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA CYAZOFAMID MARKET SIZE, BY END-USERS, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA CYAZOFAMID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA CYAZOFAMID MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA CYAZOFAMID MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA CYAZOFAMID MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA CYAZOFAMID MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA CYAZOFAMID MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA CYAZOFAMID MARKET SIZE, BY END-USERS, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA CYAZOFAMID MARKET SIZE, BY END-USERS, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA CYAZOFAMID MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA CYAZOFAMID MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA CYAZOFAMID MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA CYAZOFAMID MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA CYAZOFAMID MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA CYAZOFAMID MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA CYAZOFAMID MARKET SIZE, BY END-USERS, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA CYAZOFAMID MARKET SIZE, BY END-USERS, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE CYAZOFAMID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE CYAZOFAMID MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE CYAZOFAMID MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE CYAZOFAMID MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE CYAZOFAMID MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE CYAZOFAMID MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE CYAZOFAMID MARKET SIZE, BY END-USERS, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE CYAZOFAMID MARKET SIZE, BY END-USERS, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST CYAZOFAMID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST CYAZOFAMID MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST CYAZOFAMID MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST CYAZOFAMID MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST CYAZOFAMID MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST CYAZOFAMID MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST CYAZOFAMID MARKET SIZE, BY END-USERS, 2018-2024 (USD MILLION)
  • TABLE 220. MIDDLE EAST CYAZOFAMID MARKET SIZE, BY END-USERS, 2025-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 222. MIDDLE EAST CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA CYAZOFAMID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA CYAZOFAMID MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA CYAZOFAMID MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA CYAZOFAMID MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA CYAZOFAMID MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA CYAZOFAMID MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA CYAZOFAMID MARKET SIZE, BY END-USERS, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA CYAZOFAMID MARKET SIZE, BY END-USERS, 2025-2032 (USD MILLION)
  • TABLE 235. AFRICA CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 236. AFRICA CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC CYAZOFAMID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC CYAZOFAMID MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC CYAZOFAMID MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC CYAZOFAMID MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC CYAZOFAMID MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC CYAZOFAMID MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC CYAZOFAMID MARKET SIZE, BY END-USERS, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC CYAZOFAMID MARKET SIZE, BY END-USERS, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL CYAZOFAMID MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL CYAZOFAMID MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN CYAZOFAMID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN CYAZOFAMID MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. ASEAN CYAZOFAMID MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 256. ASEAN CYAZOFAMID MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 257. ASEAN CYAZOFAMID MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 258. ASEAN CYAZOFAMID MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. ASEAN CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
  • TABLE 262. ASEAN CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
  • TABLE 263. ASEAN CYAZOFAMID MARKET SIZE, BY END-USERS, 2018-2024 (USD MILLION)
  • TABLE 264. ASEAN CYAZOFAMID MARKET SIZE, BY END-USERS, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 267. GCC CYAZOFAMID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GCC CYAZOFAMID MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GCC CYAZOFAMID MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 270. GCC CYAZOFAMID MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 271. GCC CYAZOFAMID MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 272. GCC CYAZOFAMID MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 273. GCC CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. GCC CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. GCC CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
  • TABLE 276. GCC CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
  • TABLE 277. GCC CYAZOFAMID MARKET SIZE, BY END-USERS, 2018-2024 (USD MILLION)
  • TABLE 278. GCC CYAZOFAMID MARKET SIZE, BY END-USERS, 2025-2032 (USD MILLION)
  • TABLE 279. GCC CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 280. GCC CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION CYAZOFAMID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPEAN UNION CYAZOFAMID MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION CYAZOFAMID MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPEAN UNION CYAZOFAMID MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION CYAZOFAMID MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPEAN UNION CYAZOFAMID MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPEAN UNION CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPEAN UNION CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION CYAZOFAMID MARKET SIZE, BY END-USERS, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPEAN UNION CYAZOFAMID MARKET SIZE, BY END-USERS, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPEAN UNION CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 295. BRICS CYAZOFAMID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. BRICS CYAZOFAMID MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. BRICS CYAZOFAMID MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 298. BRICS CYAZOFAMID MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 299. BRICS CYAZOFAMID MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 300. BRICS CYAZOFAMID MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 301. BRICS CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. BRICS CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. BRICS CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
  • TABLE 304. BRICS CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
  • TABLE 305. BRICS CYAZOFAMID MARKET SIZE, BY END-USERS, 2018-2024 (USD MILLION)
  • TABLE 306. BRICS CYAZOFAMID MARKET SIZE, BY END-USERS, 2025-2032 (USD MILLION)
  • TABLE 307. BRICS CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 308. BRICS CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 309. G7 CYAZOFAMID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 310. G7 CYAZOFAMID MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 311. G7 CYAZOFAMID MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 312. G7 CYAZOFAMID MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 313. G7 CYAZOFAMID MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 314. G7 CYAZOFAMID MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 315. G7 CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. G7 CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. G7 CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
  • TABLE 318. G7 CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
  • TABLE 319. G7 CYAZOFAMID MARKET SIZE, BY END-USERS, 2018-2024 (USD MILLION)
  • TABLE 320. G7 CYAZOFAMID MARKET SIZE, BY END-USERS, 2025-2032 (USD MILLION)
  • TABLE 321. G7 CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 322. G7 CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 323. NATO CYAZOFAMID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 324. NATO CYAZOFAMID MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 325. NATO CYAZOFAMID MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 326. NATO CYAZOFAMID MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 327. NATO CYAZOFAMID MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 328. NATO CYAZOFAMID MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 329. NATO CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. NATO CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 331. NATO CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
  • TABLE 332. NATO CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
  • TABLE 333. NATO CYAZOFAMID MARKET SIZE, BY END-USERS, 2018-2024 (USD MILLION)
  • TABLE 334. NATO CYAZOFAMID MARKET SIZE, BY END-USERS, 2025-2032 (USD MILLION)
  • TABLE 335. NATO CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 336. NATO CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 337. GLOBAL CYAZOFAMID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 338. GLOBAL CYAZOFAMID MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 339. UNITED STATES CYAZOFAMID MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 340. UNITED STATES CYAZOFAMID MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 341. UNITED STATES CYAZOFAMID MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 342. UNITED STATES CYAZOFAMID MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 343. UNITED STATES CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 344. UNITED STATES CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 345. UNITED STATES CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
  • TABLE 346. UNITED STATES CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
  • TABLE 347. UNITED STATES CYAZOFAMID MARKET SIZE, BY END-USERS, 2018-2024 (USD MILLION)
  • TABLE 348. UNITED STATES CYAZOFAMID MARKET SIZE, BY END-USERS, 2025-2032 (USD MILLION)
  • TABLE 349. UNITED STATES CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 350. UNITED STATES CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 351. CANADA CYAZOFAMID MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 352. CANADA CYAZOFAMID MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 353. CANADA CYAZOFAMID MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 354. CANADA CYAZOFAMID MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 355. CANADA CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 356. CANADA CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 357. CANADA CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2018-2024 (USD MILLION)
  • TABLE 358. CANADA CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 2025-2032 (USD MILLION)
  • TABLE 359. CANADA CYAZOFAMID MARKET SIZE, BY END-USERS, 2018-2024 (USD MILLION)
  • TABLE 360. CANADA CYAZOFAMID MARKET SIZE, BY END-USERS, 2025-2032 (USD MILLION)
  • TABLE 361. CANADA CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 362. CANADA CYAZOFAMID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 363. MEXICO CYAZOFAMID MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 364. MEXICO CYAZOFAMID MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 365. MEXICO CYAZOFAMID MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 366. MEXICO CYAZOFAMID MARKET SIZE, BY PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 367. MEXICO CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 368. MEXICO CYAZOFAMID MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 369. MEXICO CYAZOFAMID MARKET SIZE, BY APPLICATION MODE, 20